Singapore markets closed

Swedish Orphan Biovitrum AB (publ) (SOBI.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
252.40+1.60 (+0.64%)
As of 12:35PM CET. Market open.
Full screen
Previous close250.80
Bid252.20 x 0
Ask252.40 x 0
Day's range249.60 - 253.20
52-week range194.47 - 273.80
Avg. volume631,763
Market cap85.68B
Beta (5Y monthly)0.22
PE ratio (TTM)28.52
EPS (TTM)8.85
Earnings date06 Feb 2024 - 12 Feb 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est298.36
  • PR Newswire

    Sobi to present new data at ASH 2023 Annual Meeting

    Sobi® will present new data at the 65th Annual Meeting of the American Society of Hematology (ASH) in San Diego from the 9th to the 12th of December 2023. During the meeting several analyses will be presented in patients with haemophilia A, paroxysmal nocturnal hemoglobinuria (PNH), immune thrombocytopenia (ITP), relapsed or refractory diffuse large b-cell lymphoma, myelofibrosis, and haemophagocytic lymphohistiocytosis.

  • PR Newswire

    Sobi has completed the issuances of series C shares

    The Board of Directors of Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) ("Sobi") has, as previously communicated, on 31 October 2023 resolved to issue redeemable and convertible series C shares and to, conditional upon subscription and payment from Svenska Handelsbanken AB, repurchase all issued series C shares, to secure Sobi's obligations under the outstanding incentive programmes. Svenska Handelsbanken AB has today subscribed for all 602,482 issued series C shares, and the new share

  • Zacks

    Swedish Orphan Biovitrum (BIOVF) Q3 Earnings Miss Estimates

    Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of -44.44% and 7.69%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?